Table 2 Seroprevalence of antibodies to Toxoplasma gondii according to pregnancy and HIV status

IgG⁺

HIV-positive

7/17 (41.2 %) (18.4–67.1)

36/73 (49.3 %) (37.4–61.3)

43/90 (47.8 %) (37.1–58.6)

86/178 (48.3 %) (40.8–55.9)

HIV-negative

37/73 (50.7 %) (38.7–62.6)

6/15 (40 %) (16.3–76.7)

43/88 (48.9 %) (38.1–59.7)

IgM⁺

HIV-positive

2/17 (11.8 %) (1.6–36.4)

14/73 (19.2 %) (10.9–30.1)

16/90 (17.8 %) (10.5–27.2)

30/178 (16.9 %) (11.7–23.2)

HIV-negative

10/73 (13.7 %) (6.8–23.7)

4/15 (26.7 %) (7.8–55.1)

14/88 (15.9 %) (9.0–25.2)

IgG⁺ and IgM⁺

HIV-positive

1/17 (5.9 %) (0.1–28.7)

10/73 (13.7 %) (6.8–23.7)

11/90 (12.2 %) (6.3–20.8)

19/178 (10.7 %) (6.6–16.2)

HIV-negative

7/73 (9.6 %) (3.9–18.8)

1/15 (6.7 %) (0.2–31.9)

8/88 (9.1 %) (4.0–17.1)

IgG⁺ or IgM⁺

HIV-positive

8/17 (47.1 %) (22.9–72.2)

40/73 (54.8 %) (1.5–13.4)

48/90 (53.3 %) (42.5–63.9)

97/178 (54.5 %) (46.9–70.0)

HIV-negative

40/73 (54.8 %) (42.7–66.5)

9/15 (60 %) (32.3–83.7)

49/88 (55.7 %) (44.7–66.3)